Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Cash from Investing Activities (2021 - 2025)

Biote has reported Cash from Investing Activities over the past 5 years, most recently at -$2.4 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$2.4 million for Q4 2025, down 80.32% from a year ago — trailing twelve months through Dec 2025 was -$6.9 million (up 63.49% YoY), and the annual figure for FY2025 was -$6.9 million, up 63.49%.
  • Cash from Investing Activities for Q4 2025 was -$2.4 million at Biote, down from -$690000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for BTMD hit a ceiling of $316.1 million in Q2 2021 and a floor of -$317.5 million in Q1 2021.
  • Median Cash from Investing Activities over the past 5 years was -$1.2 million (2021), compared with a mean of -$1.7 million.
  • Biggest five-year swings in Cash from Investing Activities: soared 6208.04% in 2023 and later crashed 3104.21% in 2024.
  • Biote's Cash from Investing Activities stood at -$1.0 million in 2021, then soared by 70.3% to -$311000.0 in 2022, then soared by 6208.04% to $19.0 million in 2023, then tumbled by 106.9% to -$1.3 million in 2024, then plummeted by 80.32% to -$2.4 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$2.4 million (Q4 2025), -$690000.0 (Q3 2025), and -$2.0 million (Q2 2025) per Business Quant data.